Not all traumatic brain injury patients on preinjury anticoagulation are the same
- PMID: 37301645
- DOI: 10.1016/j.amjsurg.2023.05.034
Not all traumatic brain injury patients on preinjury anticoagulation are the same
Abstract
Background: Prognostic significance of different anticoagulants in TBI patients remains unanswered. We aimed to compare effects of different anticoagulants on outcomes of TBI patients.
Methods: A secondary analysis of AAST BIG MIT. Blunt TBI patients ≥50 years using anticoagulants presenting ICH were identified. Outcomes were progression of ICH and need for neurosurgical intervention (NSI).
Results: 393 patients were identified. Mean age was 74 and most common anticoagulant was aspirin (30%), followed by Plavix (28%), and coumadin (20%). 20% had progression of ICH and 10% underwent NSI. On multivariate regression for ICH progression, warfarin, SDH, IPH, SAH, alcohol intoxication and neurologic exam deterioration were associated with increased odds. Warfarin, abnormal neurologic exam on presentation, and SDH were independent predictors of NSI.
Conclusions: Our findings reflect a dynamic interaction between type of anticoagulants, bleeding pattern & outcomes. Future modifications of BIG may need to take the type of anticoagulant into consideration.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest There are no identifiable conflicts of interest to report.
Comment in
-
Not all traumatic brain injury patients on preinjury anticoagulation are the same.Am J Surg. 2023 Dec;226(6):784. doi: 10.1016/j.amjsurg.2023.09.018. Epub 2023 Oct 6. Am J Surg. 2023. PMID: 37833196 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
